performers

A construction industry awards ceremony has sparked controversy over sexism after female performers appeared wearing skimpy clothing, leading to widespread criticism and calls for change within the sector. On The Tools, an online…

Stock Heat Map from FinViz.com Friday, July 26, 2024 13:46:06 GMTMarket OverviewToday's session in the stock market showed a clear duality, with the technology sector seeing a notable rise, led primarily by semiconductor giants and a mixed…

Dogecoin and Shiba Inu are starting to lose their market dominance despite being the largest cryptocurrencies. In terms of returns, newer meme coins have performed better, leaving the OGs in the dust as they continue to take…

Bitcoin, along with the rest of the market, had a very beneficial week driven by the hype and actual approval of Ethereum ETFs in the US. The weekly gauge shows that UNI, PEPE, LDO, and ETH are among the leaders in terms of…

Breadcrumb linksBMN BusinessArticle writer:Posted on May 19, 2024 • Last updated 1 hour ago • 2 min read You can save this article by registering for free here. Or log in if you have an account.FILE - Visitors follow Mickey Mouse for…

Bitcoin’s price increases continued in the early hours of the Asian trading session, and the asset neared $49,000 for the first time since the ETF approvals a month ago but was stopped there. Most altcoins have also turned…

The past week or so was quite bullish for the crypto market with bitcoin leading the pack by charting an 11% increase that drove it to well beyond $40,000. Although most alts have retraced on a daily scale now, their weekly…

Bitcoin’s price initiated another leg up in the late hours of Saturday and jumped to its highest level in over a year and a half at almost $40,000. Ethereum and Chainlink are among the best-performing larger-cap alts on a…

Bitcoin finally initiated a leg up in the past 24 hours that resulted in nearing $27,000, but the asset was swiftly rejected at that point. Several altcoins have performed better within the same timeframe, with ETH…

iQoncept Buoyed by booming diabetes drug sales, Eli Lilly (New York Stock Exchange: LLY) was the best performer in big pharma or biotech in the first half of 2023, returning dazzling 28%. Coming in at number two, Vertex Pharmaceuticals…